Masitinib as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis : a randomized clinical trial
-
Mora, J. S. (ALS Unit. Hospital San Rafael)
;
Genge, A. (Department of Neurology and Neurosurgery. Montreal Neurological Institute and Hospital. McGill University) ;
Chiò, Adriano (Department of Neuroscience. University of Turin) ;
Estol, C. J. (Neurological Center for Treatment and Rehabilitation) ;
Chaverri, Daniel (Hospital Carlos III (Madrid)) ;
Hernández, M. (Hospital Carlos III (Madrid)) ;
Marín, S. (Hospital Carlos III (Madrid)) ;
Mascias, J. (Hospital Carlos III (Madrid)) ;
Rodriguez, G. E. (Neurology Department. Neuron Motor Disease Clinic. Hospital JM Ramos) ;
Povedano, M. (Institut d'Investigació Biomèdica de Bellvitge) ;
Paipa, A. (Institut d'Investigació Biomèdica de Bellvitge) ;
Dominguez, Raúl (Institut d'Investigació Biomèdica de Bellvitge) ;
Gamez, Josep (Hospital Universitari Vall d'Hebron) ;
Salvado, M. (Hospital Universitari Vall d'Hebron) ;
Lunetta, C. (NEMO Clinical Centre. Serena Onlus Foundation) ;
Ballario, C. (Neurorosario) ;
Riva, N. (Department of Neurology-INSPE. San Raffaele Scientific Institute) ;
Mandrioli, J. (Department of Neurosciences. St. Agostino-Estense Hospital. Azienda Ospedaliero Universitaria di Modena) ;
Moussy, A. (AB Science) ;
Kinet, J. P. (Department of Pathology. Harvard Medical School and Beth Israel Deaconess Medical Center) ;
Auclair, C. (Department of Biology. Université Paris Sud Université Paris-Saclay CNRS UMR 8113. Ecole Normale Supérieure de Cachan) ;
Dubreuil, P. (Institut Paoli-Calmettes Cancer Centre (Marsella, França)) ;
Arnold, V. (AB Science) ;
Mansfield, C. D. (AB Science) ;
Hermine, O. (Imagine Institute. INSERM UMR 1163 and CNRS ERL 8254. Laboratory of Cellular and Molecular Mechanisms of Hemathological Disorders and Therapeutic Implication. Hôpital Necker) ;
Universitat Autònoma de Barcelona